AlpInvest Partners’s ESSA Pharma EPIX Stock Holding History

AlpInvest Partners’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-39,930	Closed	-$73K	–	24
2022 Q3	$73K	Sell	39,930 -66,461	-62%	-$175K	0.02%	29
2022 Q2	$335K	Hold	106,391	–	–	0.11%	22
2022 Q1	$657K	Buy	+106,391	New	+$935K	0.21%	21
2021 Q4	–	Sell	-21,646	Closed	-$173K	–	28
2021 Q3	$173K	Hold	21,646	–	–	0.07%	20
2021 Q2	$618K	Buy	+21,646	New	+$629K	0.3%	12

Other funds holding EPIX

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

ABG

Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

AlpInvest Partners's EPIX Position: Q4 2022 in Review

AlpInvest Partners sold out of ESSA Pharma (EPIX) in Q4 2022, closing a stake of 39,930 shares — an estimated $73K sold.

AlpInvest Partners first reported a position in EPIX in Q2 2021 and held it in 5 quarters. The position peaked at $657K in Q1 2022. 45 funds tracked by Wall St. Rank hold EPIX as of Q4 2022.

AlpInvest Partners reported no remaining ESSA Pharma position as of Q4 2022 after selling out during the quarter.
AlpInvest Partners sold 39,930 ESSA Pharma shares in Q4 2022, an estimated $73K.
AlpInvest Partners first reported a position in ESSA Pharma in Q2 2021 and held it in 5 quarters.
AlpInvest Partners's ESSA Pharma position peaked at $657K in Q1 2022.
45 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2022.

Based on AlpInvest Partners's 13F filing for Q4 2022, filed 10 Feb 2023.